{
    "id": "dbpedia_8013_1",
    "rank": 56,
    "data": {
        "url": "https://www.abpi.org.uk/covid-19/what-are-pharmaceutical-companies-doing-to-tackle-covid-19/",
        "read_more_link": "",
        "language": "en",
        "title": "What are pharmaceutical companies doing to tackle COVID-19?",
        "top_image": "",
        "meta_img": "",
        "images": [
            "https://www.abpi.org.uk/media/mmfn3sw5/abpi_logo_new.png",
            "https://www.abpi.org.uk/assets/images/search-dark-icon.svg",
            "https://www.abpi.org.uk/assets/images/icon-arrow-right.svg",
            "https://www.abpi.org.uk/assets/images/icon-arrow-right.svg",
            "https://www.abpi.org.uk/assets/images/icon-arrow-right.svg",
            "https://www.abpi.org.uk/assets/images/icon-arrow-right.svg",
            "https://www.abpi.org.uk/assets/images/icon-arrow-right.svg",
            "https://www.abpi.org.uk/assets/images/search-dark-icon.svg",
            "https://www.abpi.org.uk/assets/images/burger-icon.svg",
            "https://www.abpi.org.uk/assets/images/icon-search.svg",
            "https://www.abpi.org.uk/assets/images/menu-arrow-down.svg",
            "https://www.abpi.org.uk/media/mmfn3sw5/abpi_logo_new.png",
            "https://www.abpi.org.uk/media/wd4hqmop/pif-tick.png?width=173&height=130&mode=max",
            "https://www.abpi.org.uk/assets/images/twitter-footer.png",
            "https://www.abpi.org.uk/assets/images/LinkedIn.png",
            "https://www.abpi.org.uk/assets/images/YouTube.png"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "There are significant global efforts underway to diagnose, treat and prevent infections from the virus. Pharmaceutical companies are working globally to combat COVID-19.",
        "meta_lang": "en",
        "meta_favicon": "",
        "meta_site_name": "",
        "canonical_link": "https://www.abpi.org.uk/covid-19/what-are-pharmaceutical-companies-doing-to-tackle-covid-19/",
        "text": "AstraZeneca is collaborating with more than 20 partners to scale up supply of the Oxford/AstraZeneca vaccine, including through the multilateral COVAX initiative. This includes Oxford BioMedica and CP pharmaceuticals in the UK.\n\nJohnson & Johnson works with more than 12 partners on their vaccine, including Sanofi and Merck & Co.\n\nNovavax collaborates with 14 partners, including Takeda in Japan and GSK in the UK.\n\nPfizer and BioNTech have more than 10 partners to manufacture and distribute their vaccine around the world. This includes a collaboration with Biovac to manufacture and distribute Covid-19 vaccine doses within Africa.\n\nModerna has more than 20 partners, including Lonza in the EU.\n\nRead more about pharmaceutical company collaborations in ‘Unprecendented: The Rapid Innovation Response to COVID-19 and the Role of Intellectual Property’.\n\nGSK is also working with Canadian biopharmaceutical company Medicago, to develop a COVID-19 vaccine by combining Medicago’s plant-derived vaccine candidate with GSK's adjuvant technology. The companies have announced phase 3 trial results.\n\nCurevac and the UK Government are collaborating on the development of vaccines against COVID-19."
    }
}